Citigroup Maintains Buy on Adient, Lowers Price Target to $27
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Citigroup analyst Michael Ward maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $29 to $27.
Citigroup analyst Michael Ward maintains Adient (NYSE:ADNT) with a Buy and lowers the price target from $29 to $27.